In physiochemical terms, the Angiotensin-converting enzyme 2 (ACE2) is known to function as an entry receptor for COVID-19, and obesity may lead to greater levels of ACE2 expression in the lung epithelial cells. The gene discussed is ACE2; the disease is obesity disorder.